The influence of sequential, in vitro passage on secretion of matrix metalloproteinases by human brain tumour cells

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 121-128

  Rossi, Marisa ^a   Rooprai, Harcharan K ^a   Maidment, Stephen L ^a   Rucklidge, Garry J ^b   Pilkington, Geoffrey J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Brain tumours; Extracellular matrix; Matrix metalloproteinases; Tissue inhibitors of metalloproteinases

Indexed keywords

ACETIC ACID DERIVATIVE; COLLAGENASE; ENZYME PRECURSOR; GELATINASE; GELATINASE B; STROMELYSIN;

ARTICLE; ASTROCYTE; BIOPSY; BRAIN TUMOR; CELL CULTURE; CELL LINE; CELL SECRETION; CELL SELECTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; EXTRACELLULAR MATRIX; FETUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KARYOTYPE EVOLUTION; PRIORITY JOURNAL;

ASTROCYTOMA; BRAIN NEOPLASMS; EPENDYMOMA; GLIOMA; HUMANS; MEDULLOBLASTOMA; METALLOENDOPEPTIDASES; TUMOR CELLS, CULTURED;

EID: 0029929518     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling TIG 6: 121125, 1990.
2. Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB 5: 2145-2154, 1991.
3. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
4. Romanic AM and Madri JA: Extracellular matrix-degrading proteinases in the nervous system. Brain Pathl 4: 145-156, 1994.
5. Okada Y, Nagase H and Harris ED Jr. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem 261: 14245-14255, 1986.
6. Nagase H, Barrett AJ and Woessner JF Jr: Nomenclature and glossary of the matrix metalloproteinases. Matrix Suppl 1: 421-424, 1992.
7. 73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci USA 87: 364-368, 1990.
8. Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margulies IMK and Liotta LA: The activation of human type IV collagenase proenzyme. J Biol Chem 264: 1353-1356, 1989.
9. Pavloff N, Staskus PW, Kishnani NS and Hawkes SP: A new inhibitor of metalloproteinases from chicken: ChIMP-3. J Biol Chem 267: 17321-17326, 1992.
10. Sconthal A, Herrlich P, Rahnsdorf HJ and Ponta H: Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 54: 325-334, 1988.
11. Maidment SL, Merzak A, Koochekpour S, Rooprai HK, Rucklidge GJ and Pilkington GJ: The effect of exogenous gangliosides on matrix metalloproteinase secretion by human glioma cells in-vitro. (submitted).
12. Chen TR and Nierman WC: Chromosome painting and quantitative karyotyping of colon adrenocarcinoma cell lines, DLD-1 and HCT-15. Anticancer Res 14: 109-112, 1994.
13. Westphal M, Hansel M, Hamel W, Knuzmann R and Holzel F: Karotype analyses of 20 human glioma cell lines. Acta Neurochir Wein 126: 17-20, 1994.
14. Anker L, Ohgaki H, Ludeke BI, Hermann HD, Kleihues P and Westphal M: p53 protein accumulation and gene mutations in human glioma cell lines. Int J Cancer 55: 902-907, 1993.
15. Burke JM: Cytochrome oxidase activity in bovine and human retinal pigment epithelium: topographical and age-related differences. Curr Eye Res 12: 1073-1079, 1993.
16. Ponten J and Macintyre EH: Long term culture of normal and neoplastic human glia. Acta Path Microbiol Scandinav 74: 465-486, 1968.
17. Westermark B: Growth control of normal and neoplastic human glialike cells in culture.(Dissertation). Acta Universitatis Upsaliensis. 164: 448, 1973.
18. Collins VP: Cultured human glia and glioma cells. Inter Review Expt Path 24: 135201, 1983.
19. Rutka JT, Giblin JR, Dougherty DY, Liu HC, McCulloch JR, Bell CW, Stem RS, Wilson CB and Rosenblum ML: Establishment and characterization of five cell lines derived from human malignant gliomas. Acta Neuropath. (Berlin) 75: 92-103, 1987.
20. Newcombe J, Meeson A and Cuzner ML: Immunocytochemical characterization of primary glial cell cultures from normal adult human brain. Neuropath Appld Neurobiol 14: 453465, 1988.
21. Knott JCA, Edwards AJ, Gullan RW, Clarke TM and Pilkington GJ: A human glioma cell retaining expression of GFAP and gangliosides. recognized by A2B5 and LB1 antibodies, after prolonged passage. Neuropath Appld Neurobiol 16 489-500, 1990.
22. Ikeno Y, Shimokawa I, Higami Y and Ikeda T: GFAP expression in the subcutaneous tumors of mature glial cell line (HITS glioma) derived from ENU-induced rat glioma J Neurooncol 17: 191-204, 1993.
23. Saggu HK and Pilkington GJ: Immunocytochemical characterization of the A15 A5 transplantable brain tumours in vivo. Neuropath Appld Neurobiol 12: 291-303, 1986.
24. Rucklidge GJ, Lund-Johansen M, Milne G and Bjerkvig R. Isolation and characterization of a metalloprotease secreted by rat glioma cells in serum-free culture. Biochem Biophys Res Commun 172: 544-550, 1990.
25. Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR and Rosenblum ML: Expression of metalloproteinases and metalloproteinase inhibitors of fetal astrocytes and glioma cells. Cancer Res 50: 2322-2329, 1990.
26. Rooprai HK, Maidment SL, Rucklidge GJ and Pilkington GJ: Expression of four matrix metalloproteinases by cultured human brain tumour cells derived from tumours of varying histological type and grade (submitted).
27. Merzak A, Koochekpour S, Sherbert GV and Pilkington GJ: Overexpression of the 18A2/mtsl gene and down-regulation of the TIMP-2 gene in invasive human glioma cell lines in vitro. Neuropath Appld Neurobiol 20: 614-619, 1994.
28. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA and Sawaya R: Elevated levels of Mr 92,000 type IV collagenase in human brain tumours. Cancer Res 53: 2208-2211, 1993.
29. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T and Okada Y: Production of matrix metalloproteinases and tissue inhibitors of metallopioteinases-1 by human brain tumors. J Neurosurg 81: 69-77, 1994.
30. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamishita K, and Hayakawa T: Matrix metalloproteinase 9 (92 k-Da gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. J Biol Chem 267: 21712-21719, 1992.
31. Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ and Edwards DR: Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol Res 5: 19-28, 1993.
32. Koochekpour S, Merzak A and Pilkington GJ: Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma cell lines. Eur J Cancer 31: 375-380, 1995.
33. He CS, Wilheim SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ and Goldberg GI: Tissue cooperation in a proteotytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 86: 2632-2636, 1989.
34. Halaka AN, Bunning RAD, Bird CC, Gibson M and Reynolds JJ: Production of collagenase and inhibitor (TIMP) by intracranial tumours and dura in vitro. J Neurosurg 59: 461-466, 1983.
35. Nakano A, Tani E, Miyazaki K, Furuyama J and Matsumoto T. Expression of matrilysin and stromelysin in human glioma cells. Biochem Biophys Res Comm 192: 999-1003, 1993.
36. Brown JL, Lukeis R, Palvidis Z, Wass J, Raghavan D and Russell PJ: Karyotypic analysis of a heterogeneous human transitional cell carcinoma of the bladder. Cancer Genet Cytogenet 72: 116-125, 1994.